Status:
UNKNOWN
A WeChat-based Intervention to Support Breastfeeding
Lead Sponsor:
Chengdu Jinjiang Maternity and Child Health Hospital
Collaborating Sponsors:
Chengdu Women's and Children's Central Hospital
Curtin University
Conditions:
Exclusive Breastfeeding
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The aim of the randomized controlled trial (RCT) is to evaluate the effects of an intervention program delivered via WeChat platform to support exclusive breastfeeding in China. WeChat, a free smart p...
Eligibility Criteria
Inclusion
- own a smart phone;
- 18 years or above;
- sufficient language skills (completed secondary school education);
- carry a singleton fetus;
- at a gestational age of 28 to 30 weeks;
Exclusion
- have existing medical conditions or pregnancy complications which may inhibit breastfeeding initiation, according to their medical doctor;
- intend to give birth in health institutes other than the study hospitals.
Key Trial Info
Start Date :
June 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04499404
Start Date
June 28 2020
End Date
December 31 2022
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chengdu Qingyang Maternal and Child Health Hospital
Chengdu, China